Skip to content
Events

Details

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
7 Nov. 2019
3:00 PM
Location
North America
Affiliation
Illumina, Inc.
Presenter
Phil Febbo
Topic
Oncology, Cancer research
Watch Now

Related Events

Mar 31
Integrating Liquid Biopsy into Routine Cancer Pathways
Mar 31, 2026
Liquid biopsy is increasingly being adopted to support tumour profiling across cancer pathways, particularly where tissue is limited or results are needed quickly. Attendees will gain insights into where liquid biopsy adds value, challenges encountered during implementation, and how earlier molecular insights can support treatment decision‑making in routine clinical practice.
View Event
Apr 19
From circulating signals to spatial context: Multiomic insights for next‑generation cancer research
Apr 19, 2026
Connect circulating DNA and methylation signals with spatial transcriptomics to sharpen cancer detection and insight.
View Event
Apr 19
American Association for Cancer Research® (AACR) Annual Meeting 2026
Apr 19, 2026 – Apr 22, 2026
AACR 2026: Multiomic liquid biopsy to spatial insights. Attend Illumina Spotlight Theater April 19 and visit booth 4727.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.